Robert W Baird
View Older Stories View More Recent Stories
-
Baird Upgrades First Financial Bancorp (FFBC) to Outperform
-
Baird Upgrades Xueda Education (XUE) to Outperform
-
Baird Starts Swisher Hygiene (SWSH) at Outperform
-
Baird Downgrades Theravance Inc. (THRX) to Neutral
-
Baird Upgrades Encore Energy Partners (ENP) to Outperform
-
Affymetrix (AFFX) calls active on flat volatility as shares rally on upgrade
-
Notable 52-Week Highs and Lows of the Day 06/02: (AFFX) (BRCD) (NLY) High; (PSUN) (JNY) (CWTR) Low
-
Morning Movers 06/02: (HIL) (COCO) (OWW) (GMR) Higher; (XIDE) (VRA) (CYBX) Lower
-
Notable Analyst Rating Changes 06/02: (AFFX) (JNJ) (DV) Upgraded; (GIS) (ES) (SRE) Downgraded
-
Baird Upgrades Affymetrix (AFFX) to Outperform
-
Baird Downgrades Telvent Git (TLVT) to Underperform
-
Baird Upgrades Inergy (NRGY) to Outperform
-
Baird Reiterates a 'Neutral' on Alexion Pharmaceuticals (ALXN); Soliris Priority Review in aHUS Fully Expected
-
Baird Lifts Price Target On Optimer (OPTR) On Premium Price and Confidence About Label
-
UPDATE: Baird Upgrades AMAG Pharmaceuticals (AMAG) to Outperform, Raises Price Target to $22,
-
Baird Upgrades AMAG Pharmaceuticals (AMAG) to Outperform
-
Notable 52-Week Highs and Lows of the Day 05/27: (CVS) (GLUU) High; (CNIT) (ITRI) Low
-
Notable Analyst Rating Changes 05/27: (CXO) (APC) (AEG) Upgraded; (WY) (AFL) (ITRI) Downgraded
-
Morning Movers 05/27: (AATI) (FTWR) (RUE) (SEAC) Higher; (GMAN) (CINT) (MHS) (CRDC) Lower
-
Baird Cuts Itron (ITRI) to Underperform; Shares Falling
-
Notable Analyst Rating Changes 05/26: (HST) (FITB) (CTSH) Upgraded; (RSH) (LULU) (CAVM) Downgraded
-
Baird Starts Sequans Communications (SQNS) at Outperform
-
Baird Starts Martin Midstream Partners (MMLP) at Neutral
-
Baird Maintains Bullish Stance On Human Genome Sciences (HGSI) Following CHMP Positive Opinion for Benlysta
-
Baird Upgrades Vocus, Inc. (VOCS) to Outperform
-
Baird Starts Allscripts-Misys Healthcare (MDRX) at Outperform
-
Baird Starts SandRidge Mississippian Trust (SDT) at Neutral
-
Baird reiterates an 'Outperform' on Amgen (AMGN); Full Dmab '147 Data About Everything We Had Hoped For
-
Notable Analyst Rating Changes 05/17: (AONE) (PDM) (CVA) Upgraded; (CREE) (NYX) (FXCM) Downgraded
-
Baird Starts SandRidge Energy (SD) at Neutral
-
Baird Upgrades Forward Air (FWRD) to Outperform
-
Notable Analyst Rating Changes 05/16: (F) (MGM) (FITB) Higher; (KNX) (MGA) (HTLD) Downgraded
-
Baird Downgrades Heartland Express (HTLD) to Neutral
-
Baird Downgrades Knight Transportation (KNX) to Neutral
-
Baird Upgrades Jacobs Engineering (JEC) to Outperform
-
Baird Starts QR Energy (QRE) at Neutral
-
Baird Upgrades Ventas (VTR) to Neutral
-
Baird Downgrades Animal Health International (AHII) to Neutral
-
Sabre Industries (SABR) Sees IPO Price of $12 - $14/Share
-
Notable Analyst Rating Changes 05/11: (SYMC) (NR) (ATI) Upgraded; (GS) (CSCO) (AEO) Downgraded
-
SRAM International (SRAM) Files $300M IPO
-
Baird Downgrades Cisco (CSCO) to Neutral
-
Baird Downgrades Sun Hydraulics (SNHY) to Neutral
-
Complete Genomics (GNOM) Files 4.5M Common Shelf
-
Baird Starts Regency Energy Partners (RGNC) at Outperform
-
Baird Downgrades Obagi Medical Products (OMPI) to Neutral
-
Baird Upgrades Triangle Capital (TCAP) to Outperform
-
Baird Upgrades Sally Beauty Holdings (SBH) to Outperform
-
Baird Upgrades Genpact Ltd. (G) to Outperform
-
Baird Upgrades Faro Technologies (FARO) to Outperform
